Literature DB >> 11970984

Aberrant expression of Fas ligand in mice deficient for the MHC class II transactivator.

Tania S Gourley1, Dipak R Patel, Kevin Nickerson, Soon-Cheol Hong, Cheong-Hee Chang.   

Abstract

The MHC class II transactivator (CIITA) is a critical regulator of MHC class II genes and other genes involved in the Ag presentation pathway. CIITA-deficient mice lack MHC class II expression on almost all APCs. In this study, we show that these mice also have aberrant Fas ligand expression on both CD4 T cells and B cells. We found that Fas ligand expression was greatly increased on CIITA-deficient CD4 T cells during the Th1 differentiation process. However, both CIITA-deficient and control Th1 effector cells up-regulated Fas ligand to similar levels if cells were reactivated. The introduction of CIITA into primary CD4 T cells via retroviral infection resulted in a reduction in the level of Fas ligand and delay in apoptosis after activation. Interestingly, activated B cells from the CIITA-deficient mice also showed increased levels of Fas ligand that could be to some degree inhibited by the introduction of IL-4.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11970984     DOI: 10.4049/jimmunol.168.9.4414

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator.

Authors:  Simone Cenci; Gianluca Toraldo; M Neale Weitzmann; Cristiana Roggia; Yuhao Gao; Wei Ping Qian; Oscar Sierra; Roberto Pacifici
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-15       Impact factor: 11.205

Review 2.  Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy.

Authors:  Cecilia Frecha; Camille Lévy; François-Loïc Cosset; Els Verhoeyen
Journal:  Mol Ther       Date:  2010-08-24       Impact factor: 11.454

3.  Chromosomal clustering of genes controlled by the aire transcription factor.

Authors:  Jonathan B Johnnidis; Emily S Venanzi; Debra J Taxman; Jenny P-Y Ting; Christophe O Benoist; Diane J Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-09       Impact factor: 11.205

Review 4.  The PYRIN domain in signal transduction.

Authors:  Christian Stehlik
Journal:  Curr Protein Pept Sci       Date:  2007-06       Impact factor: 3.272

Review 5.  Killer B lymphocytes: the evidence and the potential.

Authors:  Steven K Lundy
Journal:  Inflamm Res       Date:  2009-03-05       Impact factor: 4.575

6.  Regulation of IL-17 expression by the developmental pathway of CD4 T cells in the thymus.

Authors:  M Hanief Sofi; Zhiping Liu; Lingqiao Zhu; Qiao Yu; Mark H Kaplan; Cheong-Hee Chang
Journal:  Mol Immunol       Date:  2010-01-18       Impact factor: 4.407

7.  Overexpression of CIITA in T cells aggravates Th2-mediated colitis in mice.

Authors:  Tae Woon Kim; Hyo Jin Park; Eun Young Choi; Kyeong Cheon Jung
Journal:  J Korean Med Sci       Date:  2006-10       Impact factor: 2.153

8.  Role of PKCdelta in IFN-gamma-inducible CIITA gene expression.

Authors:  Myung-Ja Kwon; Yongxue Yao; Michael J Walter; Michael J Holtzman; Cheong-Hee Chang
Journal:  Mol Immunol       Date:  2007-03-07       Impact factor: 4.407

9.  Revisiting the specificity of the MHC class II transactivator CIITA in classical murine dendritic cells in vivo.

Authors:  David A Anderson; Gary E Grajales-Reyes; Ansuman T Satpathy; Carlos E Vasquez Hueichucura; Theresa L Murphy; Kenneth M Murphy
Journal:  Eur J Immunol       Date:  2017-07-14       Impact factor: 5.532

10.  Development of potent class II transactivator gene delivery systems capable of inducing de novo MHC II expression in human cells, in vitro and ex vivo.

Authors:  M L Palma; P Duangkhae; B Douradinha; I F T Viana; P O Rigato; R Dhalia; R B Mailliard; S M Barratt-Boyes; E J M Nascimento; T M Oshiro; A J da Silva Duarte; E T A Marques
Journal:  Gene Ther       Date:  2017-04-17       Impact factor: 4.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.